Biogen's Medicare mess & pharmacies look past Covid-19 testing

Taking stock of the drug industry, from the lab to the medicine chest  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

STAT+: With its Alzheimer's drug in turmoil, Biogen eyes a list of potential acquisitions By Damian Garde and Adam Feuerstein Steven Senn/AP Biogen, desperate to reverse the turmoil surrounding its controversial Alzheimer’s treatment, has a shopping list of potential acquisitions. Read More With its Aduhelm proposal, Medicare is stepping into a heated debate about how best to improve equity in Alzheimer's treatment By Nicholas Florko Luca Bruno/AP With its proposal to restrict access to an Alzheimer's drug, Medicare joins a debate about addressing inequities in treatment for the disease Read More STAT+: FDA warns Chinese manufacturer for lack of vision when making sterile eye drops By Ed Silverman Karen Bleier/AFP/Getty Images The FDA noted the company distributed batches of eye drops to the U.S. market without conducting sterility testing. Read More Sponsor content by STAT Events The Breakthrough Science Summit: Early bird access! We’re gathering pharma executives, cutting-edge researchers, and key investors to break down the technologies and procedures pushing forward health and medicine. Together, we’ll explore the breakthroughs that have the potential to redefine care in the years to come. Join us there on Mar. 31! Get your ticket today and enjoy early bird pricing, available only through Jan. 14. Listen: #JPM22 in review, Biogen's worsening fortunes, & the future of RNA drugs By Damian Garde and Meg Tirrell and Adam Feuerstein STAT health tech correspondent Katie Palmer joins us this episode to recap the J.P. Morgan Healthcare Conference. Read More Thursday, January 13, 2022       1 Exchange Pl, Suite 201, Boston, MA 02109 ©2022, All Rights Reserved. I no longer wish to receive STAT emails Update Email Preferences | Contact Us | View In Browser